Convergence between Wnt-β-catenin and EGFR signaling in cancer.
about
Endocannabinoid system as a regulator of tumor cell malignancy - biological pathways and clinical significanceIndividualized treatment of gastric cancer: Impact of molecular biology and pathohistological featuresCurrent Understanding on EGFR and Wnt/β-Catenin Signaling in Glioma and Their Possible CrosstalkRegulation of amphiregulin gene expression by β-catenin signaling in human hepatocellular carcinoma cells: a novel crosstalk between FGF19 and the EGFR systemTLR4 activates the β-catenin pathway to cause intestinal neoplasiaAlternative signaling pathways as potential therapeutic targets for overcoming EGFR and c-Met inhibitor resistance in non-small cell lung cancerMechanism of Resistance and Novel Targets Mediating Resistance to EGFR and c-Met Tyrosine Kinase Inhibitors in Non-Small Cell Lung CancerTFF3-dependent resistance of human colorectal adenocarcinoma cells HT-29/B6 to apoptosis is mediated by miR-491-5p regulation of lncRNA PRINSEvaluation of a novel approach to circulating tumor cell isolation for cancer gene panel analysis in patients with breast cancer.Decorin deficiency promotes hepatic carcinogenesisTransient anabolic effects accompany epidermal growth factor receptor signal activation in articular cartilage in vivo.GPCRs and cancerAutocrine motility factor modulates EGF-mediated invasion signaling.Treatment of glioblastoma multiforme using a combination of small interfering RNA targeting epidermal growth factor receptor and β-catenin.Wnt signaling in cancerWnt5A expression is associated with the tumor metastasis and clinical survival in cervical cancer.Targeting the oncogenic MUC1-C protein inhibits mutant EGFR-mediated signaling and survival in non-small cell lung cancer cellsChemopreventive effects of berberine on intestinal tumor development in Apcmin/+ miceSrc-mediated cross-talk between farnesoid X and epidermal growth factor receptors inhibits human intestinal cell proliferation and tumorigenesis.Animal models of colitis-associated carcinogenesis.PKG II inhibits EGF/EGFR-induced migration of gastric cancer cellsLoss of desmocollin-2 confers a tumorigenic phenotype to colonic epithelial cells through activation of Akt/β-catenin signalingIncreased activation of the Wnt/β-catenin pathway in spontaneous hepatocellular carcinoma observed in farnesoid X receptor knockout mice.Side population cells of pancreatic cancer show characteristics of cancer stem cells responsible for resistance and metastasis.Computational modeling of the interplay between cadherin-mediated cell adhesion and Wnt signaling pathwayPathway profiling and rational trial design for studies in advanced stage cervical carcinoma: a review and a perspective.Transcriptional profiling of PRKG2-null growth plate identifies putative down-stream targets of PRKG2.Signal transducers and activators of transcription 3 (STAT3) directly regulates cytokine-induced fascin expression and is required for breast cancer cell migration.Multiple gene aberrations and breast cancer: lessons from super-responders.Combined inhibition of EGFR and c-ABL suppresses the growth of triple-negative breast cancer growth through inhibition of HOTAIR.Identification of Genetic Mutations in Human Lung Cancer by Targeted Sequencing.TRIM29 functions as an oncogene in gastric cancer and is regulated by miR-185Frequent amplification of AIB1, a critical oncogene modulating major signaling pathways, is associated with poor survival in gastric cancer.Src-mediated aryl hydrocarbon and epidermal growth factor receptor cross talk stimulates colon cancer cell proliferationMechanism of β-catenin-mediated transcriptional regulation of epidermal growth factor receptor expression in glycogen synthase kinase 3 β-inactivated prostate cancer cellsIntegrated Analysis of Genome-Wide Copy Number Alterations and Gene Expression Profiling of Lung Cancer in Xuanwei, ChinaTET-catalyzed 5-hydroxymethylcytosine regulates gene expression in differentiating colonocytes and colon cancerThe Metastasis Suppressor, N-MYC Downstream-regulated Gene-1 (NDRG1), Down-regulates the ErbB Family of Receptors to Inhibit Downstream Oncogenic Signaling PathwaysCurcumin inhibits tumor epithelial‑mesenchymal transition by downregulating the Wnt signaling pathway and upregulating NKD2 expression in colon cancer cellsCanonical Wnt/β-catenin signaling drives human schwann cell transformation, progression, and tumor maintenance
P2860
Q26739831-715D0BB9-2C0C-4700-9FBC-BB7A3F7E2BE1Q26776198-9109CAD5-1E88-473D-BE5C-EFA1ED56C352Q26865911-0A2A4B5D-5CC4-495E-AB3B-00C886203425Q28484499-E7D730E8-2A61-4227-8C91-898835EEB142Q28488011-AFFFA0BA-72FF-4B1E-A5BF-AA46C6A59793Q28534819-AFEC910D-D27F-464B-8994-8665A5F9496AQ28547446-356AB8B7-7DC3-44FB-A222-C29D1EA5BB77Q28817898-E68C9F07-0446-4C98-B172-CECE3DB99597Q33684887-75EDC85A-8834-4B3B-BD95-F0D6E45FC0A4Q33690924-B044FAEE-E053-49FD-8AE5-B75A0783CDA7Q33765924-3CF3C459-2569-4A8D-B7FE-EB4597120617Q33828719-456F4B68-1C29-4C95-AE56-D6514FED231FQ33881000-688081DA-CB7E-4358-A05A-975CCDBD1A0DQ34205345-58F6A6CF-7A24-47D6-93A2-CE4A5357A6EFQ34262857-C864C298-B255-4E1B-AF1D-3C4270FB49B8Q34371581-E9DA3F59-6585-415A-AB1C-9614C1C70543Q34449722-F94FE70E-CA90-45FE-90A3-62E052ABA0A2Q34464171-21025D41-7DC5-4967-974B-1D3196EF96B5Q34465146-CF18CBE1-7F7E-4A01-8CFE-04F12596F203Q34512820-912189A4-22EB-4CA2-AB4B-2B18C91AC0ECQ34684803-3CF0838C-EFF7-45D8-9955-53B683192E63Q34803102-E18DA628-C732-46B7-AAA4-FE20FEA9C82AQ35077956-FA94655D-CEBC-4BA4-B3E0-8124AB966349Q35192383-E5846B79-BB96-4305-99CC-DFB315A0EBBAQ35195352-1A013170-90C1-44B4-A442-9405ECB5501FQ35374477-793CDD47-0D94-4BAB-B658-1C2CD00F56C2Q35568706-2E2F7CF6-4449-454F-AEE1-859C14FE4266Q35604202-B360404E-5BD9-40FE-8AB7-FDFF7798A87BQ35645466-DD9DFD7B-DBBC-40A5-848C-3CB18C3A8668Q35793747-ECF7CCF8-A871-4076-B863-214ECB0B53CBQ35811159-575E0B7C-2510-4AA2-B864-7402BA70D6A2Q35854054-B44FF62F-39C0-4FAD-86FF-E5EDF4DDD925Q35987349-A76397F5-7C99-4B9C-BBAE-166DEAB02440Q35994001-64403E5F-2885-40F1-B08B-534DDBF93BE2Q36002945-2D3C83A6-3978-4AF2-B939-AC0047406F28Q36240493-F7BFEBDB-C9B1-4B9D-B562-F66C7671D548Q36343320-D8C5EC9A-13CC-46F2-8756-892A7BB9396AQ36466104-16831EEF-146C-4200-9868-62A0A1BE4DB2Q36738664-2EF5A902-1177-4BAB-99AE-EF7FE7D1679BQ36920489-96B5EA58-4967-415C-91BA-FFCDE9829830
P2860
Convergence between Wnt-β-catenin and EGFR signaling in cancer.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Convergence between Wnt-β-catenin and EGFR signaling in cancer.
@ast
Convergence between Wnt-β-catenin and EGFR signaling in cancer.
@en
Convergence between Wnt-β-catenin and EGFR signaling in cancer.
@nl
type
label
Convergence between Wnt-β-catenin and EGFR signaling in cancer.
@ast
Convergence between Wnt-β-catenin and EGFR signaling in cancer.
@en
Convergence between Wnt-β-catenin and EGFR signaling in cancer.
@nl
prefLabel
Convergence between Wnt-β-catenin and EGFR signaling in cancer.
@ast
Convergence between Wnt-β-catenin and EGFR signaling in cancer.
@en
Convergence between Wnt-β-catenin and EGFR signaling in cancer.
@nl
P2860
P921
P356
P1433
P1476
Convergence between Wnt-β-catenin and EGFR signaling in cancer.
@en
P2093
P2860
P2888
P356
10.1186/1476-4598-9-236
P5008
P577
2010-09-09T00:00:00Z
P5875
P6179
1006707629